Beneficient (NASDAQ:BENF – Get Free Report)’s stock price fell 5.7% during mid-day trading on Monday . The company traded as low as $3.31 and last traded at $3.45. 27,012 shares were traded during mid-day trading, an increase of 3% from the average session volume of 26,172 shares. The stock had previously closed at $3.66.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. Wall Street Zen raised Beneficient from a “sell” rating to a “hold” rating in a research note on Saturday, February 21st. Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research note on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.
Read Our Latest Stock Report on BENF
Beneficient Stock Up 2.2%
Institutional Investors Weigh In On Beneficient
A hedge fund recently bought a new stake in Beneficient stock. Jane Street Group LLC bought a new position in shares of Beneficient (NASDAQ:BENF – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 18,922 shares of the company’s stock, valued at approximately $133,000. Jane Street Group LLC owned 0.14% of Beneficient at the end of the most recent reporting period. Institutional investors own 90.57% of the company’s stock.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
See Also
- Five stocks we like better than Beneficient
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
